Gene Symbol | Pearson Correlation Coefficient |
---|---|
BTAF1 | 0.845 |
ZKSCAN8 | 0.841 |
DENND4C | 0.832 |
AQR | 0.832 |
MCM9 | 0.831 |
ZSCAN12 | 0.827 |
ANKHD1 | 0.826 |
PHC3 | 0.817 |
THAP6 | 0.813 |
SLC30A7 | 0.811 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
OR4F5 | -0.329 |
NANOS3 | -0.328 |
OR4F29 | -0.309 |
LCN1 | -0.283 |
NPW | -0.269 |
APOA1 | -0.265 |
C4orf48 | -0.263 |
ADRA2C | -0.251 |
ASPDH | -0.236 |
MUC12 | -0.235 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C557741 | 1-(propoxymethyl)maleimide | 1-(propoxymethyl)maleimide results in decreased activity of WRN protein | 21220316 |
C024829 | 8-hydroxyguanine | WRN protein results in decreased susceptibility to 8-hydroxyguanine | 25730140 |
D000677 | Amsacrine | WRN gene mutant form results in increased susceptibility to Amsacrine | 10725663 |
D001151 | Arsenic | Arsenic results in increased expression of WRN mRNA | 25460668 |
D001280 | Atrazine | Atrazine results in increased expression of WRN mRNA | 25929836 |
D001280 | Atrazine | Atrazine results in decreased expression of WRN mRNA | 22378314 |
D001554 | Benzene | WRN gene SNP results in increased susceptibility to Benzene | 16728435 |
D001554 | Benzene | WRN SNP affects the susceptibility to Benzene | 18978339 |
D001564 | Benzo(a)pyrene | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of WRN mRNA] | 22228805 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of WRN mRNA | 22228805 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of WRN mRNA" | 19150397 |
C000611646 | bisphenol F | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of WRN mRNA | 28628672 |
C074702 | chromium hexavalent ion | chromium hexavalent ion affects the localization of WRN protein | 19487340 |
C074702 | chromium hexavalent ion | WRN protein mutant form results in increased susceptibility to chromium hexavalent ion | 19487340 |
C074702 | chromium hexavalent ion | WRN protein results in decreased susceptibility to chromium hexavalent ion | 20585393 |
D003471 | Cuprizone | Cuprizone results in decreased expression of WRN mRNA | 27523638 |
D016572 | Cyclosporine | Cyclosporine results in increased expression of WRN mRNA | 20106945|2556210 |
C017160 | cypermethrin | cypermethrin results in increased expression of WRN mRNA | 21142847 |
D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of WRN mRNA | 28628672 |
D002945 | Cisplatin | Cisplatin results in decreased expression of WRN mRNA | 27594783 |
D002945 | Cisplatin | Cisplatin results in increased expression of WRN mRNA | 21151649 |
D002945 | Cisplatin | Cisplatin results in increased expression of WRN protein | 21416250 |
C000944 | dicrotophos | dicrotophos results in decreased expression of WRN mRNA | 28302478 |
D005047 | Etoposide | WRN gene mutant form results in increased susceptibility to Etoposide | 10725663 |
C031927 | hydroquinone | WRN gene mutant form promotes the reaction [hydroquinone results in increased expression of H2AFX protein alternative form] | 21267443 |
C031927 | hydroquinone | WRN gene mutant form results in increased susceptibility to hydroquinone | 21267443 |
C031927 | hydroquinone | WRN protein affects the reaction [hydroquinone results in increased acetylation of TP53 protein] | 17875398 |
C031927 | hydroquinone | WRN protein affects the reaction [hydroquinone results in increased expression of H2AFX protein] | 17875398 |
C031927 | hydroquinone | WRN protein affects the reaction [hydroquinone results in increased expression of TP53 protein] | 17875398 |
C031927 | hydroquinone | WRN protein inhibits the reaction [hydroquinone results in increased cleavage of CASP7 protein] | 19064679 |
C031927 | hydroquinone | WRN protein inhibits the reaction [hydroquinone results in increased cleavage of PARP1 protein] | 19064679 |
C031927 | hydroquinone | WRN protein results in decreased susceptibility to hydroquinone | 17875398|1897833 |
D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of WRN mRNA | 28628672 |
D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of WRN mRNA | 28628672 |
C544151 | jinfukang | jinfukang results in decreased expression of WRN mRNA | 27392435 |
D007649 | Ketamine | Ketamine results in decreased expression of WRN mRNA | 20080153 |
C017096 | n-butoxyethanol | n-butoxyethanol results in increased expression of WRN mRNA | 19812364 |
D010416 | Pentachlorophenol | Pentachlorophenol results in increased expression of WRN mRNA | 23892564 |
C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of WRN mRNA | 19710929 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of WRN mRNA | 23557933 |
C059514 | resveratrol | resveratrol affects the localization of WRN protein | 19559722 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of WRN protein | 19072884 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of WRN mRNA | 21354282 |
C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in increased expression of WRN mRNA" | 26179874 |
D014635 | Valproic Acid | Valproic Acid affects the expression of WRN mRNA | 25979313 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of WRN mRNA | 23179753|2718838 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of WRN mRNA | 29154799 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000287 | magnesium ion binding | - | IBA | 21873635 |
GO:0000287 | magnesium ion binding | - | IDA | 16622405 |
GO:0000400 | four-way junction DNA binding | - | IBA | 21873635 |
GO:0000400 | four-way junction DNA binding | - | IDA | 11735402 |
GO:0000403 | Y-form DNA binding | - | IBA | 21873635 |
GO:0000403 | Y-form DNA binding | - | IDA | 11735402 17715146 26420422 |
GO:0000405 | bubble DNA binding | - | IBA | 21873635 |
GO:0000405 | bubble DNA binding | - | IDA | 11433031 11735402 |
GO:0003677 | DNA binding | - | IBA | 21873635 |
GO:0003677 | DNA binding | - | IDA | 9288107 |
GO:0003678 | DNA helicase activity | - | IDA | 12944467 19734539 26420422 |
GO:0003678 | DNA helicase activity | - | IMP | 10871376 |
GO:0003682 | chromatin binding | - | IBA | 21873635 |
GO:0003682 | chromatin binding | - | IEA | - |
GO:0004003 | ATP-dependent DNA helicase activity | - | IDA | 9288107 15200954 |
GO:0004386 | helicase activity | - | IDA | 12181313 |
GO:0004527 | exonuclease activity | - | IDA | 12944467 |
GO:0004527 | exonuclease activity | - | IMP | 15200954 |
GO:0005515 | protein binding | - | IPI | 10373438 10783163 11328876 11427532 11598021 11919194 12181313 12750383 14596914 14657243 14688284 14734561 15733840 15735006 15965237 16030011 17498979 17611195 17715146 17961633 18203716 19343720 20802463 21639834 24126761 25931448 26496610 |
GO:0005524 | ATP binding | - | IEA | - |
GO:0008408 | 3'-5' exonuclease activity | - | IBA | 21873635 |
GO:0008408 | 3'-5' exonuclease activity | - | IDA | 10783163 10871373 12181313 16622405 |
GO:0009378 | four-way junction helicase activity | - | IBA | 21873635 |
GO:0009378 | four-way junction helicase activity | - | IDA | 11433031 11735402 |
GO:0016887 | ATPase activity | - | IDA | 10373438 10871376 |
GO:0030145 | manganese ion binding | - | IBA | 21873635 |
GO:0030145 | manganese ion binding | - | IDA | 16622405 |
GO:0042803 | protein homodimerization activity | - | IBA | 21873635 |
GO:0042803 | protein homodimerization activity | - | IDA | 10783163 |
GO:0043138 | 3'-5' DNA helicase activity | - | IDA | 17715146 |
GO:0043140 | ATP-dependent 3'-5' DNA helicase activity | - | IBA | 21873635 |
GO:0044877 | protein-containing complex binding | - | IDA | 10783163 |
GO:0051880 | G-quadruplex DNA binding | - | IDA | 11433031 11735402 |
GO:0061749 | forked DNA-dependent helicase activity | - | IBA | 21873635 |
GO:0061749 | forked DNA-dependent helicase activity | - | IDA | 11735402 |
GO:0061821 | telomeric D-loop binding | - | IBA | 21873635 |
GO:0061821 | telomeric D-loop binding | - | IDA | 19734539 26420422 |
GO:0061849 | telomeric G-quadruplex DNA binding | - | IC | 19734539 |
GO:0070337 | 3'-flap-structured DNA binding | - | IBA | 21873635 |
GO:0070337 | 3'-flap-structured DNA binding | - | IDA | 26420422 |
GO:1905773 | 8-hydroxy-2'-deoxyguanosine DNA binding | - | IBA | 21873635 |
GO:1905773 | 8-hydroxy-2'-deoxyguanosine DNA binding | - | IDA | 19734539 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000723 | telomere maintenance | - | IMP | 18212065 |
GO:0000723 | telomere maintenance | - | TAS | 25801465 |
GO:0000724 | double-strand break repair via homologous recombination | - | IBA | 21873635 |
GO:0000731 | DNA synthesis involved in DNA repair | - | IBA | 21873635 |
GO:0000731 | DNA synthesis involved in DNA repair | - | IDA | 17563354 |
GO:0001302 | replicative cell aging | - | IBA | 21873635 |
GO:0001302 | replicative cell aging | - | IEA | - |
GO:0006259 | DNA metabolic process | - | IDA | 16622405 |
GO:0006260 | DNA replication | - | IMP | 12882351 |
GO:0006260 | DNA replication | - | ISS | - |
GO:0006260 | DNA replication | - | TAS | - |
GO:0006281 | DNA repair | - | IBA | 21873635 |
GO:0006284 | base-excision repair | - | IBA | 21873635 |
GO:0006284 | base-excision repair | - | IDA | 17611195 |
GO:0006302 | double-strand break repair | - | IMP | 21639834 |
GO:0006310 | DNA recombination | - | IBA | 21873635 |
GO:0006974 | cellular response to DNA damage stimulus | - | IDA | 18203716 |
GO:0006979 | response to oxidative stress | - | IBA | 21873635 |
GO:0006979 | response to oxidative stress | - | IDA | 17611195 |
GO:0007420 | brain development | - | IEA | - |
GO:0007568 | aging | - | NAS | 9288107 |
GO:0007569 | cell aging | - | IBA | 21873635 |
GO:0007569 | cell aging | - | IMP | 18212065 |
GO:0008340 | determination of adult lifespan | - | IBA | 21873635 |
GO:0009267 | cellular response to starvation | - | IBA | 21873635 |
GO:0009267 | cellular response to starvation | - | IDA | 11420665 |
GO:0010225 | response to UV-C | - | IBA | 21873635 |
GO:0010225 | response to UV-C | - | IDA | 17563354 |
GO:0010259 | multicellular organism aging | - | IBA | 21873635 |
GO:0010259 | multicellular organism aging | - | IMP | 16673358 |
GO:0031297 | replication fork processing | - | IBA | 21873635 |
GO:0031297 | replication fork processing | - | IDA | 17115688 |
GO:0031297 | replication fork processing | - | IMP | 12882351 |
GO:0032508 | DNA duplex unwinding | - | IBA | 21873635 |
GO:0032508 | DNA duplex unwinding | - | IDA | 11735402 26420422 |
GO:0040009 | regulation of growth rate | - | IEA | - |
GO:0042981 | regulation of apoptotic process | - | IBA | 21873635 |
GO:0042981 | regulation of apoptotic process | - | IGI | 9681877 |
GO:0044806 | G-quadruplex DNA unwinding | - | IBA | 21873635 |
GO:0044806 | G-quadruplex DNA unwinding | - | IDA | 11735402 |
GO:0044806 | G-quadruplex DNA unwinding | - | ISS | - |
GO:0051345 | positive regulation of hydrolase activity | - | IBA | 21873635 |
GO:0051345 | positive regulation of hydrolase activity | - | IDA | 17611195 |
GO:0061820 | telomeric D-loop disassembly | - | IBA | 21873635 |
GO:0061820 | telomeric D-loop disassembly | - | IDA | 15200954 19734539 26420422 |
GO:0061820 | telomeric D-loop disassembly | - | IGI | 22039056 |
GO:0061820 | telomeric D-loop disassembly | - | TAS | 22039056 |
GO:0071480 | cellular response to gamma radiation | - | IBA | 21873635 |
GO:0071480 | cellular response to gamma radiation | - | IDA | 21639834 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | - | IEA | - |
GO:0090656 | t-circle formation | - | TAS | 27918544 |
GO:0098530 | positive regulation of strand invasion | - | IBA | 21873635 |
GO:0098530 | positive regulation of strand invasion | - | IDA | 26420422 |
GO:1902570 | protein localization to nucleolus | - | IDA | 11420665 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000781 | chromosome, telomeric region | - | IBA | 21873635 |
GO:0000781 | chromosome, telomeric region | - | IDA | 15200954 26420422 |
GO:0005634 | nucleus | - | IBA | 21873635 |
GO:0005654 | nucleoplasm | - | IBA | 21873635 |
GO:0005654 | nucleoplasm | - | IDA | 11420665 12944467 17498979 21639834 25801465 |
GO:0005654 | nucleoplasm | - | TAS | - |
GO:0005657 | replication fork | COLOCALIZES_WITH | IBA | 21873635 |
GO:0005657 | replication fork | - | ISS | - |
GO:0005662 | DNA replication factor A complex | COLOCALIZES_WITH | IBA | 21873635 |
GO:0005694 | chromosome | - | IBA | 21873635 |
GO:0005730 | nucleolus | - | IDA | 9618508 11420665 12181313 12944467 15200954 17498979 21639834 25801465 |
GO:0005737 | cytoplasm | - | IBA | 21873635 |
GO:0005813 | centrosome | - | IBA | 21873635 |
GO:0005813 | centrosome | - | IDA | 17498979 |
GO:0016607 | nuclear speck | - | IDA | - |
GO:0032389 | MutLalpha complex | COLOCALIZES_WITH | IBA | 21873635 |
GO:0032389 | MutLalpha complex | colocalizes_with | IDA | 17715146 |
GO:0035861 | site of double-strand break | - | IBA | 21873635 |
GO:0043005 | neuron projection | - | IEA | - |
KEGG ID | KEGG Term |
---|
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-1640170 | Cell Cycle | TAS |
R-HSA-212436 | Generic Transcription Pathway | TAS |
R-HSA-2990846 | SUMOylation | TAS |
R-HSA-3108214 | SUMOylation of DNA damage response and repair proteins | TAS |
R-HSA-3108232 | SUMO E3 ligases SUMOylate target proteins | TAS |
R-HSA-3700989 | Transcriptional Regulation by TP53 | TAS |
R-HSA-392499 | Metabolism of proteins | TAS |
R-HSA-5633007 | Regulation of TP53 Activity | TAS |
R-HSA-5685938 | HDR through Single Strand Annealing (SSA) | TAS |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | TAS |
R-HSA-5693532 | DNA Double-Strand Break Repair | TAS |
R-HSA-5693537 | Resolution of D-Loop Structures | TAS |
R-HSA-5693538 | Homology Directed Repair | TAS |
R-HSA-5693554 | Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | TAS |
R-HSA-5693567 | HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA) | TAS |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | TAS |
R-HSA-5693579 | Homologous DNA Pairing and Strand Exchange | TAS |
R-HSA-5693607 | Processing of DNA double-strand break ends | TAS |
R-HSA-5693616 | Presynaptic phase of homologous DNA pairing and strand exchange | TAS |
R-HSA-597592 | Post-translational protein modification | TAS |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | TAS |
R-HSA-69473 | G2/M DNA damage checkpoint | TAS |
R-HSA-69481 | G2/M Checkpoints | TAS |
R-HSA-69620 | Cell Cycle Checkpoints | TAS |
R-HSA-73857 | RNA Polymerase II Transcription | TAS |
R-HSA-73894 | DNA Repair | TAS |
R-HSA-74160 | Gene expression (Transcription) | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
21942242 | Association of GSTT1 polymorphism with acute myeloid leukemia risk is dependent on smoking status. (2012 Apr) | Kim HN | Leuk Lymphoma |
24924712 | [Study on gene-gene, gene-environmental interactions of DNA repair genes related with age-related cataract]. (2014 Apr 22) | Yang M | Zhonghua Yi Xue Za Zhi |